Mineralys Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Mineralys Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Mineralys Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Mineralys Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $242k | 19k | 12.91 |
| 2023-12-31 | $203k | 24k | 8.60 |
| 2023-09-30 | $86k | 9.1k | 9.51 |
| 2023-06-30 | $185k | 11k | 17.05 |
| 2023-03-31 | $145k | 9.3k | 15.64 |